Chronic Kidney Disease Drug Development (CKD3) is a uniquely focused conference that unites key opinion leaders in this field to identify and discuss the critical factors determining the success of current CKD pipelines and significantly impact the standard of care for this huge unmet medical need.

Bringing together leading experts from innovative biotechs, large pharma, academia and key service provider companies, CKD3 will present comprehensive insight into the cutting edge progress of CKD drug development research.

To learn more and to register online, visit https://ter.li/10so2k